Pfizer, Zantac
Pfizer agrees to pay up to $250M to settle Zantac cancer lawsuits - report
Pfizer (NYSE:PFE) will pay up to $250M to settle more than 10,000 U.S. lawsuits alleging that the company concealed cancer risks associated with its now-discontinued heartburn drug Zantac. The drugmaker has agreed to pay between $200M and $250M to settle the cases,
Pfizer agrees to settle over 10,000 Zantac lawsuits, Bloomberg News reports
Pfizer has agreed to settle more than 10,000 lawsuits about cancer risks related to the now discontinued heartburn drug Zantac, Bloomberg News reported on Wednesday, citing people familiar with the deal.
Pfizer Settles Zantac Lawsuits, Agrees To $250M Settlement To Reduce Liability: Report
In a bid to settle thousands of lawsuits over its discontinued heartburn drug Zantac, Pfizer Inc. (NYSE:PFE) has agreed to pay up to $250 million. What Happened: The settlement, disclosed in a Delaware court filing last week,
Pfizer agrees to settle over 10,000 Zantac cancer lawsuits in US, all details here
Pfizer Inc. has agreed to settle more than 10,000 cases accusing it of hiding the cancer risks of its Zantac heartburn drug.
Pfizer offers up to $250 mln to settle Zantac cancer lawsuits, FT reports
Pfizer will pay up to $250 million to settle more than 10,000 U.S. lawsuits over cancer risks associated with its discontinued heartburn drug Zantac, the Financial Times reported on Thursday.
Pfizer to Settle 10K Lawsuits Over Drug Linked to Cancer, Costing Company Millions
Big Pharma giant Pfizer confirmed on Wednesday that it will settle more than 10,000 lawsuits over allegations that the company
Pfizer Offers up to $250 Million to Settle Zantac Cancer Lawsuits, FT Reports
(Reuters) -Pfizer will pay up to $250 million to settle more than 10,000 U.S. lawsuits over cancer risks associated with its discontinued heartburn drug Zantac, the Financial Times reported on Thursday.
Pfizer Agrees to Settle More than 10,000 Zantac Cancer Suits
Pfizer Inc. has agreed to settle more than 10,000 cases accusing it of hiding the cancer risks of its Zantac heartburn drug, according to people familiar with the deal, the biggest of the litigation.
Pfizer to settle over 10,000 cancer lawsuits related to discontinued drug Zantac
Lawsuits were filed all over the US following the news. On Thursday, Bloomberg reported that Pfizer had agreed to settle over 10,000 of them outside of court. The terms of the set
Benefits Pro11d
Pfizer agrees to settle 10K Zantac lawsuits, as GSK trial links heartburn drug to cancer
Pfizer has agreed to settle more than 10,000 cases accusing it of hiding the cancer risks of its Zantac heartburn ...
The Day11d
Pfizer agrees to settle more than 10K Zantac cancer lawsuits
Pfizer Inc. has agreed to settle more than 10,000 cases accusing it of hiding the cancer risks of its Zantac ...
FiercePharma11d
Pfizer moves to settle more than 10,000 Zantac cases in state courts: Bloomberg
Following the lead of French pharmaceutical giant Sanofi, Pfizer has agreed to settle more than 10,000 personal-injury ...
Daily Mail11d
Pfizer agrees to settle 10,000 lawsuits accusing pharma giant of hiding cancer risks of heartburn drug Zantac
Pfizer has agreed to settle more than 10,000 lawsuits alleging it it of hiding the cancer risks of its heartburn drug Zantac. The financial details have not been revealed but pharma rival ...
The Spokesman-Review11d
Pfizer agrees to settle more than 10,000 Zantac cancer lawsuits
Pfizer Inc. has agreed to settle more than 10,000 cases accusing it of hiding the cancer risks of its Zantac heartburn drug, according to people familiar with the deal, the biggest of the ...